Glenmark Pharmaceuticals Limited — Others, 30-10-2024: Trading Window

Glenmark Pharmaceuticals has announced a Board Meeting scheduled for November 14, 2024, to approve the unaudited financial results for the second quarter and half-year ending September 30, 2024. Additionally, the trading window will be closed from September 30, 2024, to November 16, 2024, for designated personnel in compliance with insider trading regulations.